Stockreport

Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting

Humacyte, Inc.  (HUMA) 
PDF - Data presented at Annual Winter Meeting 2026 for the Vascular & Endovascular Surgery Society -  - After up to 36 months of follow-up, extremity arterial trauma patien [Read more]